BP attenuates the severity of colorectal inflammation and liver injuries caused by exposure to dextran sulfate sodium [41] and mitigates nonalcoholic fatty liver disease via JAK1/STAT3/BAX signaling [42]. This evidence concerns the gene BAX and metabolic dysfunction-associated steatotic liver disease.